NYSE:WST - West Pharmaceutical Services Stock Price, Forecast & News

West Pharmaceutical Services trades on the New York Stock Exchange (NYSE) under the ticker symbol "WST."

West Pharmaceutical Services declared a quarterly dividend on Tuesday, December 17th. Investors of record on Wednesday, January 22nd will be given a dividend of $0.16 per share on Wednesday, February 5th. This represents a $0.64 annualized dividend and a dividend yield of 0.36%. The ex-dividend date is Tuesday, January 21st. This is a positive change from West Pharmaceutical Services's previous quarterly dividend of $0.15. View West Pharmaceutical Services' Dividend History.

West Pharmaceutical Services Inc. (NYSE:WST) issued its quarterly earnings data on Thursday, February, 13th. The medical instruments supplier reported $0.82 earnings per share for the quarter, topping the consensus estimate of $0.72 by $0.10. The medical instruments supplier had revenue of $470.60 million for the quarter, compared to the consensus estimate of $451.53 million. West Pharmaceutical Services had a net margin of 13.14% and a return on equity of 17.06%. West Pharmaceutical Services's revenue was up 11.4% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.73 EPS. View West Pharmaceutical Services' Earnings History.

West Pharmaceutical Services is scheduled to release their next quarterly earnings announcement on Thursday, April 23rd 2020. View Earnings Estimates for West Pharmaceutical Services.

West Pharmaceutical Services updated its FY20 earnings guidance on Thursday, February, 13th. The company provided earnings per share guidance of $3.45-3.55 for the period, compared to the Thomson Reuters consensus estimate of $3.40. The company issued revenue guidance of $1.95-1.97 billion, compared to the consensus revenue estimate of $1.95 billion.

3 brokers have issued 12-month target prices for West Pharmaceutical Services' shares. Their forecasts range from $112.16 to $135.00. On average, they anticipate West Pharmaceutical Services' share price to reach $123.05 in the next year. This suggests that the stock has a possible downside of 30.2%. View Analyst Price Targets for West Pharmaceutical Services.

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for West Pharmaceutical Services in the last year. There are currently 1 sell rating, 1 hold rating and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for West Pharmaceutical Services.

Media headlines about WST stock have trended somewhat negative on Wednesday, InfoTrie reports. InfoTrie identifies positive and negative media coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. West Pharmaceutical Services earned a news sentiment score of -1.0 on InfoTrie's scale. They also gave news coverage about the medical instruments supplier a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an effect on the stock's share price in the immediate future. View News Stories for West Pharmaceutical Services.

West Pharmaceutical Services saw a decline in short interest in the month of January. As of January 31st, there was short interest totalling 1,020,000 shares, a decline of 23.9% from the January 15th total of 1,340,000 shares. Based on an average trading volume of 452,100 shares, the short-interest ratio is currently 2.3 days. Approximately 1.4% of the company's stock are short sold. View West Pharmaceutical Services' Current Options Chain.

Some companies that are related to West Pharmaceutical Services include Align Technology (ALGN), Cooper Companies (COO), DENTSPLY SIRONA (XRAY), Haemonetics (HAE), ICU Medical (ICUI), Neogen (NEOG), Quidel (QDEL), Merit Medical Systems (MMSI), STAAR Surgical (STAA), Atrion (ATRI), Cerus (CERS), Anika Therapeutics (ANIK), Antares Pharma (ATRS), OraSure Technologies (OSUR) and Utah Medical Products (UTMD).

Based on aggregate information from My MarketBeat watchlists, some companies that other West Pharmaceutical Services investors own include PepsiCo (PEP), Johnson & Johnson (JNJ), Mcdonald's (MCD), AbbVie (ABBV), Lowe's Companies (LOW), Medtronic (MDT), Walmart (WMT), NVIDIA (NVDA), AFLAC (AFL) and PPG Industries (PPG).

West Pharmaceutical Services' stock is owned by many different of institutional and retail investors. Top institutional shareholders include Franklin Resources Inc. (6.01%), State Street Corp (3.70%), Bamco Inc. NY (2.01%), Capital Research Global Investors (1.94%), WCM Investment Management LLC (1.81%) and Artisan Partners Limited Partnership (1.49%). Company insiders that own West Pharmaceutical Services stock include Daniel Malone, Karen Flynn, Patrick J Zenner and William J Federici. View Institutional Ownership Trends for West Pharmaceutical Services.

WST stock was sold by a variety of institutional investors in the last quarter, including Bessemer Group Inc., Bamco Inc. NY, Cubist Systematic Strategies LLC, Schroder Investment Management Group, Victory Capital Management Inc., Victory Capital Management Inc., USS Investment Management Ltd and Intermede Investment Partners Ltd. View Insider Buying and Selling for West Pharmaceutical Services.

WST stock was purchased by a variety of institutional investors in the last quarter, including State Street Corp, AJO LP, Sumitomo Mitsui Trust Holdings Inc., Renaissance Technologies LLC, Alliancebernstein L.P., Bank of Montreal Can, Swiss National Bank and Point72 Asset Management L.P.. View Insider Buying and Selling for West Pharmaceutical Services.

Shares of WST can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of WST stock can currently be purchased for approximately $176.17.

West Pharmaceutical Services has a market capitalization of $13.03 billion and generates $1.84 billion in revenue each year. The medical instruments supplier earns $241.70 million in net income (profit) each year or $3.24 on an earnings per share basis. West Pharmaceutical Services employs 7,700 workers across the globe.View Additional Information About West Pharmaceutical Services.

The official website for West Pharmaceutical Services is http://www.westpharma.com/.

West Pharmaceutical Services' mailing address is 530 HERMAN O. WEST DRIVE, EXTON PA, 19341. The medical instruments supplier can be reached via phone at 610-594-2900 or via email at [email protected]